OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program - Aurora, SK; Dodick, DW; Diener, HC; Degryse, RE; Turkel, CC; Lipton, RB (Acta Neurol Scand, 2014)
et al.